rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-7-23
|
pubmed:abstractText |
Inhaled nitric oxide (NO) has been used for pulmonary vasodilation therapy in patients with pulmonary hypertension. Inhaled NO for awake and ambulatory patients, however, is unusual because it requires intubation or a tightly fitting facemask, and a large-scale delivery system for the safe management of toxic nitrogen oxides. We undertook this study to investigate the possibility of using inhaled NO therapy for awake and ambulatory patients with pulmonary hypertension.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0918-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
429-34
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12135173-Administration, Inhalation,
pubmed-meshheading:12135173-Adult,
pubmed-meshheading:12135173-Cardiac Output,
pubmed-meshheading:12135173-Female,
pubmed-meshheading:12135173-Heart Catheterization,
pubmed-meshheading:12135173-Hemodynamics,
pubmed-meshheading:12135173-Humans,
pubmed-meshheading:12135173-Hypertension, Pulmonary,
pubmed-meshheading:12135173-Lung,
pubmed-meshheading:12135173-Male,
pubmed-meshheading:12135173-Middle Aged,
pubmed-meshheading:12135173-Nebulizers and Vaporizers,
pubmed-meshheading:12135173-Nitric Oxide,
pubmed-meshheading:12135173-Pulmonary Artery,
pubmed-meshheading:12135173-Safety,
pubmed-meshheading:12135173-Vascular Resistance,
pubmed-meshheading:12135173-Vasodilator Agents
|
pubmed:year |
2002
|
pubmed:articleTitle |
Hemodynamic effects of inhaled nitric oxide using pulse delivery and continuous delivery systems in pulmonary hypertension.
|
pubmed:affiliation |
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai.
|
pubmed:publicationType |
Journal Article
|